United Therapeutics Corporation
United Therapeutics Corporation (UTHR) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · UTHR · as of Sep 30, 2024
Ownership Breakdown
645
Institutional Holders
▲ 53 vs Q2
$15.63B
Total Inst. Value
▲ $1.02B vs Q2
42.45M
Shares Outstanding
freeFloat 91.70%
43.69M
13F Shares Held
▼ 2.20M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
UTHR largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 5.32M | 11.92% | 11.92% | $1.91T | Nov 13, 2024 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 4.41M | 9.89% | 9.89% | $1.58T | Nov 13, 2024 | ▼ 9.4K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 3.17M | 7.11% | 7.11% | $1.14T | Nov 14, 2024 | ▼ 114.4K |
AVORO CAPITAL ADVISORS LLC pharmaceutical preparations | 2.86M | 6.41% | 6.41% | $1.02T | Nov 14, 2024 | — held |
STATE STREET CORP pharmaceutical preparations | 2.24M | 5.02% | 5.02% | $802.07B | Nov 14, 2024 | ▼ 56.0K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 2.16M | 4.83% | 4.83% | $772.38B | Nov 13, 2024 | ▼ 19.3K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.09M | 2.45% | 2.45% | $391.46B | Nov 12, 2024 | ▲ 45.6K |
FMR LLC pharmaceutical preparations | 1.08M | 2.42% | 2.42% | $386.17B | Nov 13, 2024 | ▲ 314.0K |
LSV ASSET MANAGEMENT pharmaceutical preparations | 969.5K | 2.17% | 2.17% | $347.41B | Nov 12, 2024 | ▲ 3.1K |
AQR CAPITAL MANAGEMENT LLC pharmaceutical preparations | 967.7K | 2.17% | 2.17% | $346.79B | Nov 14, 2024 | ▲ 248.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
26
Increased
+2.32M shares1
New Positions
first time holders22
Decreased
−2.71M shares0
Sold Out
fully exitedNet shares change (top 50)
388.0K
+2.32M / −2.71M
Net new holders
+5
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
UTHR insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
75
Buy transactions
821
Sell transactions
0.09
Buy/Sell ratio
$2M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 120 | $539.64 | $64.8K | 28.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 480 | $541.14 | $259.7K | 28.3K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 440 | $542.78 | $238.8K | 27.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,086 | $544.11 | $590.9K | 26.8K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,545 | $544.94 | $841.9K | 25.2K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,129 | $545.89 | $616.3K | 24.1K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,033 | $547.00 | $565.1K | 23.0K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 2,749 | $548.04 | $1.51M | 20.3K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 1,298 | $549.06 | $712.7K | 19.0K | Form 4 ↗ |
EDGEMOND JAMES CFO AND TREASURER | Jun 4, 2026 | Sale | 120 | $550.48 | $66.1K | 18.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
United Therapeutics Corporation (UTHR) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 8.30%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of United Therapeutics Corporation is BLACKROCK, INC., holding approximately 5.32 million shares — equal to 11.92% of outstanding shares — as of September 30, 2024.
A total of 645 institutional investors currently hold UTHR stock, with a combined institutional value of approximately $15.63 billion as of the most recent 13F filing period.
Frequently asked questions
UTHR ownershipUnited Therapeutics Corporation (UTHR) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 11.92% stake. Company insiders hold 8.30%. Data sourced from SEC Form 13F as of September 30, 2024.